Tempus has expanded its AI-based Care Pathway Intelligence platform to cover breast cancer, following its acquisition of experience in lung, pancreatic, and ovarian cancers. The
A new technology marks a turning point in the treatment of early-stage breast cancer GammaPod, one of the most advanced innovations in the treatment of
Innoblative prepares to initiate its feasibility study, evaluating the safety and effectiveness of its SIRA® RFA Electrosurgical Device, an FDA Breakthrough Device, for patients undergoing breast-conserving
Fuel up with free Health Tech Insights
